Tempus AI Raises $410M in IPO, Sees Revenue Surge
Tempus AI sold 11M shares at $37 each, launched in 2015, focuses on medical testing, with revenue growth from $320.7M ...
- Latest
- Trending
Tempus AI sold 11M shares at $37 each, launched in 2015, focuses on medical testing, with revenue growth from $320.7M ...
Investors await a rally; data shows rising demand for Ethereum, despite an 8% price drop to $3,500. Wealthy investors continue ...
Bitcoin trading at $63,655. A Buy Sell ratio below one suggests larger sell orders. Prices typically rise when buy orders ...
Scotto, Biggar, and Liani rank among top analysts with profitable ratings & impressive average returns, according to TipRanks data. Cisco ...
The Vergecast discusses Delta getting into the App Store and what it could mean for the future of the iPhone. ...
Morgan Stanley suggests credit trouble may arise if the Fed hikes rates, as spreads widen for US investment-grade debt while ...
Altimmune's stock has seen a strong increase in value, surpassing Eli Lilly and Novo Nordisk. However, there are risks involved.
Gopinath warns that US deficits will continue to rise, contributing to global growth, while emphasizing the need for policy prescriptions.
Injective Protocol's recent upgrade to Injective 3.0 aims to increase the scarcity of the INJ token, which is currently trading ...
China's gold jewelry demand experienced a 10% increase, while India's demand fell by 6%. The country's appetite for gold is ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.